• Users Online: 183
  • Print this page
  • Email this page

    Article Cited by others


Dipeptidyl-peptidase-4 inhibitors in type 2 diabetes and COVID-19: From a potential repurposed agent to a useful treatment option

Singh Awadhesh Kumar, Singh Ritu

Year : 2020| Volume: 11| Issue : 3 | Page no: 131-136

   This article has been cited by
1 DPP-4 inhibition and COVID-19: From initial concerns to recent expectations
André J. Scheen
Diabetes & Metabolism. 2021; 47(2): 101213
[Pubmed]  [Google Scholar] [DOI]
2 Management of coronavirus disease-2019 (COVID-19) in patients with diabetes
Dhanasekaran Bodhini,Viswanathan Mohan
Journal of Diabetology. 2020; 11(3): 125
[Pubmed]  [Google Scholar] [DOI]
3 Non-insulin anti-diabetic agents in patients with type 2 diabetes and COVID-19: A Critical Appraisal of Literature
Awadhesh Kumar Singh,Ritu Singh,Banshi Saboo,Anoop Misra
Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2020;
[Pubmed]  [Google Scholar] [DOI]


Read this article